GB0821019D0 - Nanostructures suitable for delivery of agents - Google Patents

Nanostructures suitable for delivery of agents

Info

Publication number
GB0821019D0
GB0821019D0 GBGB0821019.7A GB0821019A GB0821019D0 GB 0821019 D0 GB0821019 D0 GB 0821019D0 GB 0821019 A GB0821019 A GB 0821019A GB 0821019 D0 GB0821019 D0 GB 0821019D0
Authority
GB
United Kingdom
Prior art keywords
delivery
agents
nanostructures suitable
nanostructures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0821019.7A
Other versions
GB2451599A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apollo Life Science Ltd
Original Assignee
Apollo Life Science Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apollo Life Science Ltd filed Critical Apollo Life Science Ltd
Publication of GB0821019D0 publication Critical patent/GB0821019D0/en
Publication of GB2451599A publication Critical patent/GB2451599A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
GB0821019A 2006-05-16 2008-11-17 Nanostructures suitable for delivery of agents Withdrawn GB2451599A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80089806P 2006-05-16 2006-05-16
PCT/AU2007/000655 WO2007131286A1 (en) 2006-05-16 2007-05-16 Nanostructures suitable for delivery of agents

Publications (2)

Publication Number Publication Date
GB0821019D0 true GB0821019D0 (en) 2008-12-24
GB2451599A GB2451599A (en) 2009-02-04

Family

ID=38693454

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0821019A Withdrawn GB2451599A (en) 2006-05-16 2008-11-17 Nanostructures suitable for delivery of agents

Country Status (3)

Country Link
AU (1) AU2007250536A1 (en)
GB (1) GB2451599A (en)
WO (1) WO2007131286A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9993437B2 (en) 2007-12-06 2018-06-12 The Regents Of The University Of California Mesoporous silica nanoparticles for biomedical applications
US20130079382A1 (en) 2009-10-12 2013-03-28 Larry J. Smith Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
WO2011130716A2 (en) 2010-04-16 2011-10-20 Access Pharmaceuticals, Inc. A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers
US20120207795A1 (en) 2010-07-13 2012-08-16 The Regents Of The University Of California Cationic polymer coated mesoporous silica nanoparticles and uses thereof
CN103501821A (en) 2011-03-08 2014-01-08 艾克塞斯制药公司 Targeted nanocarrier systems for delivery of actives across biological membranes
US10220004B2 (en) 2011-07-14 2019-03-05 The Regents Of The University Of California Method of controlled delivery using sub-micron-scale machines
WO2014179335A1 (en) 2013-04-29 2014-11-06 Memorial Sloan Kettering Cancer Center Compositions and methods for altering second messenger signaling
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
FR3054444A1 (en) * 2016-07-29 2018-02-02 Laboratoire Francais Du Fractionnement Et Des Biotechnologies ORAL COMPOSITION OF ANTI-TNF ALPHA ANTIBODY
EP3920934A1 (en) * 2019-02-04 2021-12-15 DSM IP Assets B.V. Therapeutic combinations and compositions for the treatment of inflammatory bowel disease (ii)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855127A (en) * 1986-07-07 1989-08-08 Dow Corning Corporation Lattice-entrapped composition
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
WO2002067995A1 (en) * 2001-02-26 2002-09-06 Council Of Scientific And Industrial Research Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines

Also Published As

Publication number Publication date
AU2007250536A1 (en) 2007-11-22
GB2451599A (en) 2009-02-04
WO2007131286A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
EP2012751A4 (en) Novel nanoparticles for delivery of active agents
GB0821019D0 (en) Nanostructures suitable for delivery of agents
GB0607866D0 (en) Nanostructures
IL213341A0 (en) Dipeptide linked medicinal agents
EP2271301A4 (en) Methods and compositions for the delivery of agents
EP2101745A4 (en) Delivery of drugs
GB0609492D0 (en) Therapeutic agents
GB0608928D0 (en) Therapeutic agents
EP2051734A4 (en) Agents for blood-brain barrier delivery
PL2418267T3 (en) Benefit agent containing delivery particle
GB0601962D0 (en) Therapeutic agents
IL221795A0 (en) Formulations for parenteral delivery of compounds and uses thereof
PL1813614T3 (en) Cytotoxic agents comprising new tomaymycin derivatives
EP2007435A4 (en) System for targeted delivery of therapeutic agents
EP2035488A4 (en) Micelles for drug delivery
EP2046736A4 (en) Arylsulfanyl compounds and compositions for delivering active agents
GB0616214D0 (en) Therapeutic Agents
EP2114145A4 (en) Phenylalkylcarboxylic acid delivery agents
EP2010162A4 (en) Drug delivery composition
GB0611152D0 (en) Therapeutic agents
EP1855669A4 (en) Liposomal compositions for parenteral delivery of agents
GB0620818D0 (en) Therapeutic agents
GB0620059D0 (en) Therapeutic agents
GB0609676D0 (en) Therapeutic agents
EP2039342A4 (en) Agent for maintaining the hardness of tooth structure

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)